Bone Medical signs distribution deal
You have no credits left. To view this article subscribe to Business News.
You have used {{points}} and have {{current_points}} remaining. Your credits will reset on {{reset_date}}.
This article is part of a special report and is available to paid Business News subscribers only.
You can purchase access to this special report or subscribe to Business News.
You can purchase access to this special report or subscribe to Business News.
This article is premium content and is available to paid Business News subscribers only.
Subscribe to Business News.
Subscribe to Business News.
Thursday, 19 June, 2008 - 13:00
Bentley-based Bone Medical Ltd has signed an initial agreement with a South Korean company to distribute an osteoporosis product in the country.
The agreement with Hyundai Pharm Co Ltd covers the terms for the grant of a licence to sell Bone's CaPTHymone product in South Korea.
Details of the agreement terms have not been released with the transaction subject to due diligence.
However Bone said it will qualify for an up-front payment , milestone payments related to product development, approval and launch events and payments for supply of bulk product.
Bone will also receive royalties on annual sales of CaPTHymone.
Companies: